Picture |
Product name |
Price |
Update |
Hits |
Contact |
|
Recombinant human Myelin P2 protein
Model: AP71991,50ug-1mg
origin of place: China
|
$260-1975 |
06/16/15 |
203
|
Get Quote |
|
Recombinant human Calreticulin
Model: AP71992,50ug-1mg
origin of place: China
|
$260-1975 |
06/16/15 |
179
|
Get Quote |
|
Recombinant human Cellular tumor antigen p53
Model: AP71993,50ug-1mg
origin of place: China
|
$260-1975 |
06/16/15 |
218
|
Get Quote |
|
Recombinant rat C-X-C motif chemokine 13 protein
Model: AP71994,50ug-1mg
origin of place: China
|
$260-1975 |
06/16/15 |
228
|
Get Quote |
|
Recombinant human Myoglobin
Model: AP71995,50ug-1mg
origin of place: China
|
$260-1975 |
06/16/15 |
219
|
Get Quote |
|
Recombinant human Myoglobin
Model: AP71996,50ug-1mg
origin of place: China
|
$260-1975 |
06/16/15 |
352
|
Get Quote |
|
Recombinant human NT-proBNP
Model: AP71997,50ug-1mg
origin of place: China
|
$260-1975 |
06/16/15 |
199
|
Get Quote |
|
Recombinant human Troponin I, cardiac muscle
Model: AP71998,50ug-1mg
origin of place: China
|
$260-1975 |
06/16/15 |
193
|
Get Quote |
|
Recombinant human Troponin I, cardiac muscle
Model: AP71999,50ug-1mg
origin of place: China
|
$260-1975 |
06/16/15 |
207
|
Get Quote |
|
Recombinant mouse Adiponectin
Model: AP72000,50ug-1mg
origin of place: China
|
$260-1975 |
06/16/15 |
228
|
Get Quote |
|
Recombinant human Adiponectin
Model: AP72001,50ug-1mg
origin of place: China
|
$260-1975 |
06/16/15 |
204
|
Get Quote |
|
Recombinant human Lactadherin protein
Model: AP72002,50ug-1mg
origin of place: China
|
$260-1975 |
06/16/15 |
201
|
Get Quote |
|
Recombinant human Lactadherin protein
Model: AP72003,50ug-1mg
origin of place: China
|
$260-1975 |
06/16/15 |
206
|
Get Quote |
|
Recombinant human Tumor necrosis factor ligand superfamily member 9 protein
Model: AP72004,50ug-1mg
origin of place: China
|
$260-1975 |
06/16/15 |
208
|
Get Quote |
|
Recombinant human Tumor necrosis factor receptor superfamily member 3
Model: AP72005,50ug-1mg
origin of place: China
|
$260-1975 |
06/16/15 |
220
|
Get Quote |